Hyperthermia, ie heating the tumor to a temperature of 40–43° C is considered by many a
valuable treatment to sensitize tumor cells to radiotherapy and chemotherapy. In recent …

Hyperthermia and liposomal drug delivery are treatment modalities that have been used to
treat cancer over the last two decades. More recently, the two therapies have been used …

Doxorubicin (Dox) loaded thermosensitive liposomes (TSLs) have shown promising results
for hyperthermia-induced local drug delivery to solid tumors. Typically, the tumor is heated to …

Introduction: Specific delivery of a drug to a target site is a major goal of drug delivery
research. Using temperature-sensitive liposomes (TSLs) is one way to achieve this; the …

Lipid-based nanocarriers or liposomes have been proven successful in the delivery of
chemotherapeutic agents and are currently applied clinically in the treatment of various …

Therapeutic hyperthermia is a procedure that involves heating tissues to a higher
temperature level, typically ranging from 41 C to 45 C. Its combination with radiotherapy …

Hyperthermia is an adjuvant local anti-cancer treatment using temperatures exceeding the
physiologically optimal level, typically 40–43◦ C for approximately one hour. Hyperthermia …

Liposomes have been employed as cancer therapy clinically since the 1990s, with the
primary benefit of reduced toxicity but no appreciable efficacy improvement …

Systemic chemotherapy of solid tumors could be enhanced by local hyperthermia (HT) in
combination with thermosensitive liposomes (TSL) as drug carriers. In such an approach …

The realization that hyperthermia was an ideal complementary treatment to radiation and
certain chemotherapeutic agents from a biologic perspective led to great enthusiasm for this …